In a recent ARCHIVES article by Flum and Koepsell,1 the authors had rather mixed cards and inappropriately called for the clinical and financial costs incurred by patients undergoing negative appendectomy (NA) to be considered when evaluating system-level interventions to improve the treatment of appendicitis. The implications of NA should be more appropriately considered when the treatment of nonspecific abdominal pain (NSAP) is evaluated.